{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:19:37Z","timestamp":1790223577860,"version":"4.1.0"},"reference-count":32,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2017]]},"DOI":"10.1536\/ihj.16-328","type":"journal-article","created":{"date-parts":[[2017,2,12]],"date-time":"2017-02-12T22:12:18Z","timestamp":1486937538000},"page":"238-244","source":"Crossref","is-referenced-by-count":64,"title":["A Randomized Comparative Study on the Efficacy of Intracoronary Infusion of Autologous Bone Marrow Mononuclear Cells and Mesenchymal Stem Cells in Patients With Dilated Cardiomyopathy"],"prefix":"10.1536","volume":"58","author":[{"given":"Wentao","family":"Xiao","sequence":"first","affiliation":[{"name":"Department of Cardiology, Henan Cardiovascular Hospital, Zhengzhou University People\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suping","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Henan Cardiovascular Hospital, Zhengzhou University People\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanyu","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Henan Cardiovascular Hospital, Zhengzhou University People\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoyou","family":"Dai","sequence":"additional","affiliation":[{"name":"Center for Translational Study, Henan Cardiovascular Hospital, Zhengzhou University People\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjv","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Henan Cardiovascular Hospital, Zhengzhou University People\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muwei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Henan Cardiovascular Hospital, Zhengzhou University People\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianpei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Henan Cardiovascular Hospital, Zhengzhou University People\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayi","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Heart Center, Peking University People\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Maron BJ, Towbin JA, Thiene G, <i>et al<\/i>. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006; 113: 1807-16.","DOI":"10.1161\/CIRCULATIONAHA.106.174287"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. K\u00e4rkk\u00e4inen S, Peuhkurinen K. Genetics of dilated cardiomyopathy. Ann Med 2007; 39: 91-107. (Review)","DOI":"10.1080\/07853890601145821"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Nagaya N, Kangawa K, Itoh T, <i>et al<\/i>. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 2005; 112: 1128-35.","DOI":"10.1161\/CIRCULATIONAHA.104.500447"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Seth S, Narang R, Bhargava B, <i>et al<\/i>. Percutaneous intracoronary cellular cardiomyoplasty for nonischemic cardiomyopathy: clinical and histopathological results: the first-in-man ABCD (Autologous Bone Marrow Cells in Dilated Cardiomyopathy) trial. J Am Coll Cardiol 2006; 48: 2350-1.","DOI":"10.1016\/j.jacc.2006.07.057"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Orlic D, Kajstura J, Chimenti S, <i>et al<\/i>. Bone marrow cells regenerate infarcted myocardium. Nature 2001; 410: 701-5.","DOI":"10.1038\/35070587"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Wollert KC, Meyer GP, Lotz J, <i>et al<\/i>. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomized controlled clinical trial. Lancet 2004; 364: 141-8.","DOI":"10.1016\/S0140-6736(04)16626-9"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Sch\u00e4chinger V, Erbs S, Els\u00e4sser A, <i>et al<\/i>. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006; 355: 1210-21.","DOI":"10.1056\/NEJMoa060186"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Assmus B, Honold J, Sch\u00e4chinger V, <i>et al<\/i>. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 2006; 355: 1222-32.","DOI":"10.1056\/NEJMoa051779"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Canetti M, Akhter MW, Lerman A, <i>et al<\/i>. Evaluation of myocardial blood flow reserve in patients with chronic congestive heart failure due to idiopathic dilated cardiomyopathy. Am J Cardiol 2003; 92: 1246-9.","DOI":"10.1016\/j.amjcard.2003.08.002"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med 2007; 356: 830-40. (Review)","DOI":"10.1056\/NEJMra061889"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Fischer-Rasokat U, Assmus B, Seeger FH, <i>et al<\/i>. A pilot trial to assess potential effects of selective intracoronary bone marrow-derived progenitor cell infusion in patients with nonischemic dilated cardiomyopathy: final 1-year results of the transplantation of progenitor cells and functional regeneration enhancement pilot trial in patients with nonischemic dilated cardiomyopathy. Circ Heart Fail 2009; 2: 417-23.","DOI":"10.1161\/CIRCHEARTFAILURE.109.855023"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Widimsky P, Penicka M. Complications after intracoronary stem cell transplantation in idiopathic dilated cardiomyopathy. Int J Cardiol 2006; 111: 178-9.","DOI":"10.1016\/j.ijcard.2005.09.055"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Martino HF, Oliveira PS, Souza FC, <i>et al<\/i>. A safety and feasibility study of cell therapy in dilated cardiomyopathy. Braz J Med Biol Res 2010; 43: 989-95.","DOI":"10.1590\/S0100-879X2010007500093"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Vrtovec B, Poglajen G, Sever M, <i>et al<\/i>. Effects of intracoronary stem cell transplantation in patients with dilated cardiomyopathy. J Card Fail 2011; 17: 272-81.","DOI":"10.1016\/j.cardfail.2010.11.007"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Beohar N, Rapp J, Pandya S, Losordo DW. Rebuilding the damaged heart: the potential of cytokines and growth factors in the treatment of ischemic heart disease. J Am Coll Car-diol 2010; 56: 1287-97. (Review)","DOI":"10.1016\/j.jacc.2010.05.039"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ziebart T, Yoon CH, Trepels T, <i>et al<\/i>. Sustained persistence of transplanted proangiogenic cells contributes to neovascularization and cardiac function after ischemia. Circ Res 2008; 103: 1327-34.","DOI":"10.1161\/CIRCRESAHA.108.180463"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Murry CE, Field LJ, Menasch\u00e9 P. Cell-based cardiac repair: reflections at the 10-year point. Circulation 2005; 112: 3174-83. (Review)","DOI":"10.1161\/CIRCULATIONAHA.105.546218"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Liu J, Sluijter JP, Goumans MJ, <i>et al<\/i>. Cell therapy for myocardial regeneration. Curr Mol Med 2009; 9: 287-98. (Review)","DOI":"10.2174\/156652409787847218"},{"key":"19","doi-asserted-by":"crossref","unstructured":"20. Garcia EV, Cooke CD, Van Train KF, <i>et al<\/i>. Technical aspects of myocardial SPECT imaging with technetium-99m sestamibi. Am J Cardiol 1990; 66: 23E-31E.","DOI":"10.1016\/0002-9149(90)90608-4"},{"key":"20","doi-asserted-by":"crossref","unstructured":"21. Assmus B, Sch\u00e4chinger V, Teupe C, <i>et al<\/i>. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 2002; 106: 3009-17.","DOI":"10.1161\/01.CIR.0000043246.74879.CD"},{"key":"21","doi-asserted-by":"crossref","unstructured":"22. Strauer BE, Brehm M, Zeus T, <i>et al<\/i>. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002; 106: 1913-8.","DOI":"10.1161\/01.CIR.0000034046.87607.1C"},{"key":"22","doi-asserted-by":"crossref","unstructured":"23. Beltrami AP, Urbanek K, Kajstura J, <i>et al<\/i>. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 2001; 344: 1750-7.","DOI":"10.1056\/NEJM200106073442303"},{"key":"23","doi-asserted-by":"crossref","unstructured":"24. Blau HM, Brazelton TR, Weimman JM. The evolving concept of a stem cell: entity or function? Cell 2001; 105: 829-41. (Review)","DOI":"10.1016\/S0092-8674(01)00409-3"},{"key":"24","doi-asserted-by":"crossref","unstructured":"25. Erbs S, Linke A, Sch\u00e4chinger V, <i>et al<\/i>. Restoration of microvascular function in the infarct-related artery by intracoronary transplantation of bone marrow progenitor cells in patients with acute myocardial infarction: the Doppler Substudy of the Reinfusion of Enriched Progenitor Cells and Infarct Remodeling in Acute Myocardial Infarction (REPAIRAMI) trial. Circulation 2007; 116: 366-74.","DOI":"10.1161\/CIRCULATIONAHA.106.671545"},{"key":"25","doi-asserted-by":"crossref","unstructured":"26. Strauer BE, Yousef M, Schannwell CM. The acute and long-term effects of intracoronary Stem cell Transplantation in 191 patients with chronic heart failure: the STAR-heart study. Eur J Heart Fail 2010; 12: 721-9.","DOI":"10.1093\/eurjhf\/hfq095"},{"key":"26","doi-asserted-by":"crossref","unstructured":"27. Seth S, Bhargava B, Narang R, <i>et al<\/i>. The ABCD (Autologous Bone Marrow Cells in Dilated Cardiomyopathy) trial a long-term follow-up study. J Am Coll Cardiol 2010; 55: 1643-4.","DOI":"10.1016\/j.jacc.2009.11.070"},{"key":"27","doi-asserted-by":"crossref","unstructured":"28. Abdel-Latif A, Bolli R, Tleyjeh IM, <i>et al<\/i>. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 2007; 167: 989-97. (Review)","DOI":"10.1001\/archinte.167.10.989"},{"key":"28","doi-asserted-by":"crossref","unstructured":"29. Iwasaki H, Kawamoto A, Ishikawa M, <i>et al<\/i>. Dose-dependent contribution of CD 34-positive cell transplantation to concurrent vasculogenesis and cardiomyogenesis for functional regenerative recovery after myocardial infarction. Circulation 2006; 113: 1311-25.","DOI":"10.1161\/CIRCULATIONAHA.105.541268"},{"key":"29","doi-asserted-by":"crossref","unstructured":"30. Quyyumi AA, Waller EK, Murrow J, <i>et al<\/i>. CD34(+) cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent. Am Heart J 2011; 161: 98-105.","DOI":"10.1016\/j.ahj.2010.09.025"},{"key":"30","doi-asserted-by":"crossref","unstructured":"31. Lezaic L, Socan A, Poglajen G, <i>et al<\/i>. Intracoronary transplantation of CD34(+) cells is associated with improved myocardial perfusion in patients with nonischemic dilated cardiomyopathy. J Card Fail 2015; 21: 145-52.","DOI":"10.1016\/j.cardfail.2014.11.005"},{"key":"31","doi-asserted-by":"crossref","unstructured":"32. Vrtovec B, Poglajen G, Lezaic L, <i>et al<\/i>. Effects of intracoronary CD34+ stem cell transplantation in non-ischemic dilated cardiomyopathy patients: 5-year follow up. Circ Res 2013; 112: 165-73.","DOI":"10.1161\/CIRCRESAHA.112.276519"},{"key":"32","doi-asserted-by":"crossref","unstructured":"33. Meyer GP, Wollert KC, Lotz J, <i>et al<\/i>. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months\u2019 follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 2006; 113: 1287-94.","DOI":"10.1161\/CIRCULATIONAHA.105.575118"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/58\/2\/58_16-328\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T10:22:29Z","timestamp":1498386149000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/58\/2\/58_16-328\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.16-328","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}